secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Teknova, Inc. (TKNO)
CIK:        0001850902
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0000950170-24-123359
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teknova Q3 revenue up 17% to $9.6M; net loss $7.6M; guidance reiterates $35-38M
-------------------------------------------------------------------------------

- Total revenue $9.6M (+17% YoY); Clinical Solutions up 229% to $2.0M; Lab Essentials flat at $7.2M.
- GAAP net loss $7.6M ($0.15 EPS); adjusted EBITDA negative $5.0M; excludes $2.8M non-cash inventory charge.
- Gross margin 0.9% (29.8% excluding $2.8M charge) vs 18.0% in Q3 2023.
- Operating expenses down to $7.5M from $10.2M YoY, driven by reduced headcount and professional fees.
- 2024 free cash outflow outlook lowered to <$16M from <$18M; revenue guidance reaffirmed at $35-38M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850902/000095017024123359/0000950170-24-123359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850902/000095017024123359/tkno-20241107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-123359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer